nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomipramine—GSTP1—lung cancer	0.239	0.645	CbGaD
Clomipramine—GSTP1—Cisplatin—lung cancer	0.0698	0.18	CbGbCtD
Clomipramine—GSTP1—Etoposide—lung cancer	0.0685	0.177	CbGbCtD
Clomipramine—ALB—lung cancer	0.0674	0.182	CbGaD
Clomipramine—ABCB1—lung cancer	0.0643	0.173	CbGaD
Clomipramine—ALB—Gefitinib—lung cancer	0.02	0.0517	CbGbCtD
Clomipramine—CYP2C19—Gefitinib—lung cancer	0.013	0.0335	CbGbCtD
Clomipramine—CYP2C19—Teniposide—lung cancer	0.0126	0.0325	CbGbCtD
Clomipramine—ALB—Erlotinib—lung cancer	0.0119	0.0306	CbGbCtD
Clomipramine—ABCB1—Topotecan—lung cancer	0.0115	0.0296	CbGbCtD
Clomipramine—ALB—Irinotecan—lung cancer	0.0107	0.0276	CbGbCtD
Clomipramine—ABCB1—Gefitinib—lung cancer	0.0105	0.027	CbGbCtD
Clomipramine—CYP2D6—Gefitinib—lung cancer	0.00988	0.0255	CbGbCtD
Clomipramine—ABCB1—Vinorelbine—lung cancer	0.00808	0.0208	CbGbCtD
Clomipramine—CYP2D6—Vinorelbine—lung cancer	0.00761	0.0196	CbGbCtD
Clomipramine—CYP1A2—Erlotinib—lung cancer	0.00709	0.0183	CbGbCtD
Clomipramine—CYP3A4—Topotecan—lung cancer	0.00687	0.0177	CbGbCtD
Clomipramine—ABCB1—Crizotinib—lung cancer	0.00643	0.0166	CbGbCtD
Clomipramine—CYP3A4—Gefitinib—lung cancer	0.00628	0.0162	CbGbCtD
Clomipramine—ABCB1—Gemcitabine—lung cancer	0.00628	0.0162	CbGbCtD
Clomipramine—ABCB1—Erlotinib—lung cancer	0.0062	0.016	CbGbCtD
Clomipramine—CYP3A4—Teniposide—lung cancer	0.00609	0.0157	CbGbCtD
Clomipramine—CYP2D6—Erlotinib—lung cancer	0.00584	0.0151	CbGbCtD
Clomipramine—ABCB1—Paclitaxel—lung cancer	0.00567	0.0146	CbGbCtD
Clomipramine—ALB—Methotrexate—lung cancer	0.00566	0.0146	CbGbCtD
Clomipramine—ABCB1—Irinotecan—lung cancer	0.0056	0.0144	CbGbCtD
Clomipramine—CYP1A2—Etoposide—lung cancer	0.00513	0.0132	CbGbCtD
Clomipramine—ABCB1—Vinblastine—lung cancer	0.00498	0.0128	CbGbCtD
Clomipramine—HTR2A—phrenic nerve—lung cancer	0.00491	0.261	CbGeAlD
Clomipramine—CYP3A4—Vinorelbine—lung cancer	0.00484	0.0125	CbGbCtD
Clomipramine—CYP2D6—Vinblastine—lung cancer	0.00469	0.0121	CbGbCtD
Clomipramine—ABCB1—Cisplatin—lung cancer	0.00456	0.0118	CbGbCtD
Clomipramine—ABCB1—Etoposide—lung cancer	0.00448	0.0116	CbGbCtD
Clomipramine—ABCB1—Docetaxel—lung cancer	0.0041	0.0106	CbGbCtD
Clomipramine—CYP3A4—Crizotinib—lung cancer	0.00385	0.00993	CbGbCtD
Clomipramine—CYP3A4—Erlotinib—lung cancer	0.00371	0.00958	CbGbCtD
Clomipramine—CYP3A4—Paclitaxel—lung cancer	0.0034	0.00877	CbGbCtD
Clomipramine—CYP3A4—Irinotecan—lung cancer	0.00335	0.00865	CbGbCtD
Clomipramine—ABCB1—Doxorubicin—lung cancer	0.00306	0.00788	CbGbCtD
Clomipramine—CYP3A4—Vinblastine—lung cancer	0.00298	0.00769	CbGbCtD
Clomipramine—ABCB1—Methotrexate—lung cancer	0.00296	0.00764	CbGbCtD
Clomipramine—CYP2D6—Doxorubicin—lung cancer	0.00288	0.00743	CbGbCtD
Clomipramine—CYP3A4—Etoposide—lung cancer	0.00269	0.00693	CbGbCtD
Clomipramine—CYP3A4—Docetaxel—lung cancer	0.00246	0.00634	CbGbCtD
Clomipramine—CYP3A4—Doxorubicin—lung cancer	0.00183	0.00472	CbGbCtD
Clomipramine—HTR2A—pulmonary artery—lung cancer	0.00178	0.0947	CbGeAlD
Clomipramine—ALB—mammary gland—lung cancer	0.000875	0.0465	CbGeAlD
Clomipramine—GSTP1—respiratory system—lung cancer	0.000681	0.0362	CbGeAlD
Clomipramine—HRH2—cardiac atrium—lung cancer	0.000656	0.0349	CbGeAlD
Clomipramine—GSTP1—epithelium—lung cancer	0.000569	0.0302	CbGeAlD
Clomipramine—SLC6A4—respiratory system—lung cancer	0.000566	0.0301	CbGeAlD
Clomipramine—GSTP1—bronchus—lung cancer	0.00056	0.0298	CbGeAlD
Clomipramine—GSTP1—trachea—lung cancer	0.000503	0.0267	CbGeAlD
Clomipramine—HRH2—lung—lung cancer	0.000502	0.0267	CbGeAlD
Clomipramine—SLC6A2—respiratory system—lung cancer	0.000499	0.0265	CbGeAlD
Clomipramine—GSTP1—cardiac atrium—lung cancer	0.000472	0.0251	CbGeAlD
Clomipramine—GSTP1—bone marrow—lung cancer	0.000399	0.0212	CbGeAlD
Clomipramine—CYP1A2—respiratory system—lung cancer	0.000383	0.0204	CbGeAlD
Clomipramine—GSTP1—lung—lung cancer	0.000361	0.0192	CbGeAlD
Clomipramine—HRH2—lymph node—lung cancer	0.000343	0.0183	CbGeAlD
Clomipramine—SLC6A4—lung—lung cancer	0.000301	0.016	CbGeAlD
Clomipramine—HTR2A—respiratory system—lung cancer	0.0003	0.0159	CbGeAlD
Clomipramine—HTR2B—lung—lung cancer	0.000298	0.0158	CbGeAlD
Clomipramine—ADRA2A—bronchus—lung cancer	0.00029	0.0154	CbGeAlD
Clomipramine—SLC6A2—lung—lung cancer	0.000265	0.0141	CbGeAlD
Clomipramine—ADRA2A—trachea—lung cancer	0.00026	0.0138	CbGeAlD
Clomipramine—HTR2A—epithelium—lung cancer	0.00025	0.0133	CbGeAlD
Clomipramine—GSTP1—lymph node—lung cancer	0.000247	0.0131	CbGeAlD
Clomipramine—ADRA2A—cardiac atrium—lung cancer	0.000245	0.013	CbGeAlD
Clomipramine—HTR2A—trachea—lung cancer	0.000221	0.0118	CbGeAlD
Clomipramine—ALB—lymph node—lung cancer	0.000212	0.0113	CbGeAlD
Clomipramine—HTR2B—lymph node—lung cancer	0.000204	0.0108	CbGeAlD
Clomipramine—CYP1A2—lung—lung cancer	0.000204	0.0108	CbGeAlD
Clomipramine—ABCB1—respiratory system—lung cancer	0.000196	0.0104	CbGeAlD
Clomipramine—ADRA2A—lung—lung cancer	0.000187	0.00995	CbGeAlD
Clomipramine—SLC6A2—lymph node—lung cancer	0.000181	0.00963	CbGeAlD
Clomipramine—ABCB1—epithelium—lung cancer	0.000164	0.00873	CbGeAlD
Clomipramine—HTR2A—lung—lung cancer	0.000159	0.00846	CbGeAlD
Clomipramine—ABCB1—trachea—lung cancer	0.000145	0.00772	CbGeAlD
Clomipramine—ADRA2A—lymph node—lung cancer	0.000128	0.00681	CbGeAlD
Clomipramine—Carbinoxamine—CYP2E1—lung cancer	0.000122	0.0734	CrCbGaD
Clomipramine—ABCB1—bone marrow—lung cancer	0.000115	0.00612	CbGeAlD
Clomipramine—ABCB1—lung—lung cancer	0.000104	0.00554	CbGeAlD
Clomipramine—Flurazepam—CYP2A6—lung cancer	0.000102	0.0614	CrCbGaD
Clomipramine—Desipramine—CYP2A6—lung cancer	8.84e-05	0.0531	CrCbGaD
Clomipramine—Nortriptyline—CYP2E1—lung cancer	7.62e-05	0.0458	CrCbGaD
Clomipramine—Thioridazine—CYP2E1—lung cancer	7.35e-05	0.0442	CrCbGaD
Clomipramine—Flurazepam—CYP2E1—lung cancer	7.25e-05	0.0436	CrCbGaD
Clomipramine—ABCB1—lymph node—lung cancer	7.13e-05	0.00379	CbGeAlD
Clomipramine—Methotrimeprazine—CYP2E1—lung cancer	7.02e-05	0.0422	CrCbGaD
Clomipramine—Desipramine—CYP2E1—lung cancer	6.28e-05	0.0377	CrCbGaD
Clomipramine—Triflupromazine—ABCB1—lung cancer	5.82e-05	0.0349	CrCbGaD
Clomipramine—Diazepam—CYP2E1—lung cancer	5.76e-05	0.0346	CrCbGaD
Clomipramine—Acepromazine—ALB—lung cancer	5.64e-05	0.0339	CrCbGaD
Clomipramine—Thioproperazine—ALB—lung cancer	5.51e-05	0.0331	CrCbGaD
Clomipramine—Pipotiazine—ALB—lung cancer	5.42e-05	0.0326	CrCbGaD
Clomipramine—Chlorpromazine—CYP2E1—lung cancer	5.35e-05	0.0322	CrCbGaD
Clomipramine—Imipramine—CYP2E1—lung cancer	5.32e-05	0.032	CrCbGaD
Clomipramine—Amitriptyline—CYP2E1—lung cancer	5.29e-05	0.0318	CrCbGaD
Clomipramine—Clobazam—ABCB1—lung cancer	5.17e-05	0.0311	CrCbGaD
Clomipramine—Nortriptyline—ALB—lung cancer	4.19e-05	0.0252	CrCbGaD
Clomipramine—Chlorprothixene—ABCB1—lung cancer	4.07e-05	0.0245	CrCbGaD
Clomipramine—Flurazepam—ABCB1—lung cancer	3.8e-05	0.0229	CrCbGaD
Clomipramine—Trimipramine—ABCB1—lung cancer	3.76e-05	0.0226	CrCbGaD
Clomipramine—Pain—Paclitaxel—lung cancer	3.64e-05	0.00025	CcSEcCtD
Clomipramine—Constipation—Paclitaxel—lung cancer	3.64e-05	0.00025	CcSEcCtD
Clomipramine—Confusional state—Docetaxel—lung cancer	3.64e-05	0.00025	CcSEcCtD
Clomipramine—Pharyngitis—Methotrexate—lung cancer	3.63e-05	0.00025	CcSEcCtD
Clomipramine—Promethazine—ABCB1—lung cancer	3.62e-05	0.0218	CrCbGaD
Clomipramine—Urinary tract disorder—Methotrexate—lung cancer	3.62e-05	0.000249	CcSEcCtD
Clomipramine—Photosensitivity reaction—Doxorubicin—lung cancer	3.62e-05	0.000249	CcSEcCtD
Clomipramine—Anaphylactic shock—Docetaxel—lung cancer	3.61e-05	0.000248	CcSEcCtD
Clomipramine—Oedema—Docetaxel—lung cancer	3.61e-05	0.000248	CcSEcCtD
Clomipramine—Weight increased—Doxorubicin—lung cancer	3.61e-05	0.000248	CcSEcCtD
Clomipramine—Pruritus—Gemcitabine—lung cancer	3.6e-05	0.000248	CcSEcCtD
Clomipramine—Urethral disorder—Methotrexate—lung cancer	3.59e-05	0.000247	CcSEcCtD
Clomipramine—Doxepin—ABCB1—lung cancer	3.59e-05	0.0216	CrCbGaD
Clomipramine—Weight decreased—Doxorubicin—lung cancer	3.58e-05	0.000247	CcSEcCtD
Clomipramine—Feeling abnormal—Etoposide—lung cancer	3.58e-05	0.000246	CcSEcCtD
Clomipramine—Trifluoperazine—ABCB1—lung cancer	3.58e-05	0.0215	CrCbGaD
Clomipramine—Hyperglycaemia—Doxorubicin—lung cancer	3.57e-05	0.000246	CcSEcCtD
Clomipramine—Diarrhoea—Irinotecan—lung cancer	3.57e-05	0.000246	CcSEcCtD
Clomipramine—Pneumonia—Doxorubicin—lung cancer	3.55e-05	0.000244	CcSEcCtD
Clomipramine—Gastrointestinal pain—Etoposide—lung cancer	3.55e-05	0.000244	CcSEcCtD
Clomipramine—Shock—Docetaxel—lung cancer	3.55e-05	0.000244	CcSEcCtD
Clomipramine—Nervous system disorder—Docetaxel—lung cancer	3.54e-05	0.000243	CcSEcCtD
Clomipramine—Thrombocytopenia—Docetaxel—lung cancer	3.53e-05	0.000243	CcSEcCtD
Clomipramine—Drowsiness—Doxorubicin—lung cancer	3.53e-05	0.000243	CcSEcCtD
Clomipramine—Visual impairment—Methotrexate—lung cancer	3.53e-05	0.000243	CcSEcCtD
Clomipramine—Tachycardia—Docetaxel—lung cancer	3.52e-05	0.000242	CcSEcCtD
Clomipramine—Feeling abnormal—Paclitaxel—lung cancer	3.51e-05	0.000241	CcSEcCtD
Clomipramine—Skin disorder—Docetaxel—lung cancer	3.51e-05	0.000241	CcSEcCtD
Clomipramine—Hypersensitivity—Cisplatin—lung cancer	3.49e-05	0.00024	CcSEcCtD
Clomipramine—Gastrointestinal pain—Paclitaxel—lung cancer	3.48e-05	0.00024	CcSEcCtD
Clomipramine—Diarrhoea—Gemcitabine—lung cancer	3.48e-05	0.000239	CcSEcCtD
Clomipramine—Neuropathy peripheral—Doxorubicin—lung cancer	3.46e-05	0.000238	CcSEcCtD
Clomipramine—Dizziness—Irinotecan—lung cancer	3.45e-05	0.000238	CcSEcCtD
Clomipramine—Urticaria—Etoposide—lung cancer	3.45e-05	0.000237	CcSEcCtD
Clomipramine—Jaundice—Doxorubicin—lung cancer	3.44e-05	0.000237	CcSEcCtD
Clomipramine—Anorexia—Docetaxel—lung cancer	3.44e-05	0.000237	CcSEcCtD
Clomipramine—Body temperature increased—Etoposide—lung cancer	3.43e-05	0.000236	CcSEcCtD
Clomipramine—Abdominal pain—Etoposide—lung cancer	3.43e-05	0.000236	CcSEcCtD
Clomipramine—Conjunctivitis—Doxorubicin—lung cancer	3.43e-05	0.000236	CcSEcCtD
Clomipramine—Urinary tract infection—Doxorubicin—lung cancer	3.43e-05	0.000236	CcSEcCtD
Clomipramine—Eye disorder—Methotrexate—lung cancer	3.42e-05	0.000235	CcSEcCtD
Clomipramine—Tinnitus—Methotrexate—lung cancer	3.41e-05	0.000235	CcSEcCtD
Clomipramine—Asthenia—Cisplatin—lung cancer	3.4e-05	0.000234	CcSEcCtD
Clomipramine—Cardiac disorder—Methotrexate—lung cancer	3.4e-05	0.000234	CcSEcCtD
Clomipramine—Sweating—Doxorubicin—lung cancer	3.39e-05	0.000233	CcSEcCtD
Clomipramine—Urticaria—Paclitaxel—lung cancer	3.38e-05	0.000233	CcSEcCtD
Clomipramine—Hypotension—Docetaxel—lung cancer	3.37e-05	0.000232	CcSEcCtD
Clomipramine—Haematuria—Doxorubicin—lung cancer	3.37e-05	0.000232	CcSEcCtD
Clomipramine—Body temperature increased—Paclitaxel—lung cancer	3.37e-05	0.000232	CcSEcCtD
Clomipramine—Abdominal pain—Paclitaxel—lung cancer	3.37e-05	0.000232	CcSEcCtD
Clomipramine—Hepatobiliary disease—Doxorubicin—lung cancer	3.34e-05	0.00023	CcSEcCtD
Clomipramine—Epistaxis—Doxorubicin—lung cancer	3.33e-05	0.000229	CcSEcCtD
Clomipramine—Angiopathy—Methotrexate—lung cancer	3.32e-05	0.000229	CcSEcCtD
Clomipramine—Vomiting—Irinotecan—lung cancer	3.32e-05	0.000228	CcSEcCtD
Clomipramine—Sinusitis—Doxorubicin—lung cancer	3.31e-05	0.000228	CcSEcCtD
Clomipramine—Immune system disorder—Methotrexate—lung cancer	3.31e-05	0.000228	CcSEcCtD
Clomipramine—Mediastinal disorder—Methotrexate—lung cancer	3.3e-05	0.000227	CcSEcCtD
Clomipramine—Agranulocytosis—Doxorubicin—lung cancer	3.3e-05	0.000227	CcSEcCtD
Clomipramine—Rash—Irinotecan—lung cancer	3.29e-05	0.000226	CcSEcCtD
Clomipramine—Desipramine—ABCB1—lung cancer	3.29e-05	0.0198	CrCbGaD
Clomipramine—Dermatitis—Irinotecan—lung cancer	3.29e-05	0.000226	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Docetaxel—lung cancer	3.29e-05	0.000226	CcSEcCtD
Clomipramine—Chills—Methotrexate—lung cancer	3.29e-05	0.000226	CcSEcCtD
Clomipramine—Headache—Irinotecan—lung cancer	3.27e-05	0.000225	CcSEcCtD
Clomipramine—Insomnia—Docetaxel—lung cancer	3.27e-05	0.000225	CcSEcCtD
Clomipramine—Diarrhoea—Cisplatin—lung cancer	3.24e-05	0.000223	CcSEcCtD
Clomipramine—Paraesthesia—Docetaxel—lung cancer	3.24e-05	0.000223	CcSEcCtD
Clomipramine—Alopecia—Methotrexate—lung cancer	3.24e-05	0.000223	CcSEcCtD
Clomipramine—Vomiting—Gemcitabine—lung cancer	3.23e-05	0.000222	CcSEcCtD
Clomipramine—Bradycardia—Doxorubicin—lung cancer	3.23e-05	0.000222	CcSEcCtD
Clomipramine—Dyspnoea—Docetaxel—lung cancer	3.22e-05	0.000221	CcSEcCtD
Clomipramine—Somnolence—Docetaxel—lung cancer	3.21e-05	0.000221	CcSEcCtD
Clomipramine—Mental disorder—Methotrexate—lung cancer	3.21e-05	0.000221	CcSEcCtD
Clomipramine—Rash—Gemcitabine—lung cancer	3.21e-05	0.000221	CcSEcCtD
Clomipramine—Dermatitis—Gemcitabine—lung cancer	3.2e-05	0.00022	CcSEcCtD
Clomipramine—Hypersensitivity—Etoposide—lung cancer	3.2e-05	0.00022	CcSEcCtD
Clomipramine—Malnutrition—Methotrexate—lung cancer	3.19e-05	0.000219	CcSEcCtD
Clomipramine—Headache—Gemcitabine—lung cancer	3.19e-05	0.000219	CcSEcCtD
Clomipramine—Rhinitis—Doxorubicin—lung cancer	3.18e-05	0.000219	CcSEcCtD
Clomipramine—Dyspepsia—Docetaxel—lung cancer	3.18e-05	0.000219	CcSEcCtD
Clomipramine—Hepatitis—Doxorubicin—lung cancer	3.17e-05	0.000218	CcSEcCtD
Clomipramine—Diazepam—ALB—lung cancer	3.17e-05	0.019	CrCbGaD
Clomipramine—Hypoaesthesia—Doxorubicin—lung cancer	3.16e-05	0.000217	CcSEcCtD
Clomipramine—Pharyngitis—Doxorubicin—lung cancer	3.15e-05	0.000216	CcSEcCtD
Clomipramine—Decreased appetite—Docetaxel—lung cancer	3.14e-05	0.000216	CcSEcCtD
Clomipramine—Hypersensitivity—Paclitaxel—lung cancer	3.14e-05	0.000216	CcSEcCtD
Clomipramine—Urinary tract disorder—Doxorubicin—lung cancer	3.13e-05	0.000215	CcSEcCtD
Clomipramine—Dysgeusia—Methotrexate—lung cancer	3.12e-05	0.000215	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Docetaxel—lung cancer	3.12e-05	0.000214	CcSEcCtD
Clomipramine—Asthenia—Etoposide—lung cancer	3.12e-05	0.000214	CcSEcCtD
Clomipramine—Connective tissue disorder—Doxorubicin—lung cancer	3.12e-05	0.000214	CcSEcCtD
Clomipramine—Fatigue—Docetaxel—lung cancer	3.11e-05	0.000214	CcSEcCtD
Clomipramine—Urethral disorder—Doxorubicin—lung cancer	3.11e-05	0.000214	CcSEcCtD
Clomipramine—Nausea—Irinotecan—lung cancer	3.1e-05	0.000213	CcSEcCtD
Clomipramine—Constipation—Docetaxel—lung cancer	3.09e-05	0.000212	CcSEcCtD
Clomipramine—Pain—Docetaxel—lung cancer	3.09e-05	0.000212	CcSEcCtD
Clomipramine—Back pain—Methotrexate—lung cancer	3.08e-05	0.000212	CcSEcCtD
Clomipramine—Pruritus—Etoposide—lung cancer	3.07e-05	0.000211	CcSEcCtD
Clomipramine—Visual impairment—Doxorubicin—lung cancer	3.06e-05	0.00021	CcSEcCtD
Clomipramine—Asthenia—Paclitaxel—lung cancer	3.06e-05	0.00021	CcSEcCtD
Clomipramine—Nausea—Gemcitabine—lung cancer	3.02e-05	0.000208	CcSEcCtD
Clomipramine—Diazepam—ABCB1—lung cancer	3.02e-05	0.0182	CrCbGaD
Clomipramine—Vomiting—Cisplatin—lung cancer	3.01e-05	0.000207	CcSEcCtD
Clomipramine—Pruritus—Paclitaxel—lung cancer	3.01e-05	0.000207	CcSEcCtD
Clomipramine—Vision blurred—Methotrexate—lung cancer	3e-05	0.000207	CcSEcCtD
Clomipramine—Rash—Cisplatin—lung cancer	2.99e-05	0.000206	CcSEcCtD
Clomipramine—Dermatitis—Cisplatin—lung cancer	2.99e-05	0.000205	CcSEcCtD
Clomipramine—Feeling abnormal—Docetaxel—lung cancer	2.97e-05	0.000205	CcSEcCtD
Clomipramine—Diarrhoea—Etoposide—lung cancer	2.97e-05	0.000204	CcSEcCtD
Clomipramine—Eye disorder—Doxorubicin—lung cancer	2.96e-05	0.000204	CcSEcCtD
Clomipramine—Ill-defined disorder—Methotrexate—lung cancer	2.96e-05	0.000203	CcSEcCtD
Clomipramine—Tinnitus—Doxorubicin—lung cancer	2.96e-05	0.000203	CcSEcCtD
Clomipramine—Gastrointestinal pain—Docetaxel—lung cancer	2.95e-05	0.000203	CcSEcCtD
Clomipramine—Anaemia—Methotrexate—lung cancer	2.95e-05	0.000203	CcSEcCtD
Clomipramine—Flushing—Doxorubicin—lung cancer	2.94e-05	0.000202	CcSEcCtD
Clomipramine—Cardiac disorder—Doxorubicin—lung cancer	2.94e-05	0.000202	CcSEcCtD
Clomipramine—Chlorpromazine—ALB—lung cancer	2.94e-05	0.0177	CrCbGaD
Clomipramine—Diarrhoea—Paclitaxel—lung cancer	2.91e-05	0.0002	CcSEcCtD
Clomipramine—Amitriptyline—ALB—lung cancer	2.91e-05	0.0175	CrCbGaD
Clomipramine—Angiopathy—Doxorubicin—lung cancer	2.88e-05	0.000198	CcSEcCtD
Clomipramine—Malaise—Methotrexate—lung cancer	2.87e-05	0.000198	CcSEcCtD
Clomipramine—Dizziness—Etoposide—lung cancer	2.87e-05	0.000198	CcSEcCtD
Clomipramine—Immune system disorder—Doxorubicin—lung cancer	2.86e-05	0.000197	CcSEcCtD
Clomipramine—Vertigo—Methotrexate—lung cancer	2.86e-05	0.000197	CcSEcCtD
Clomipramine—Mediastinal disorder—Doxorubicin—lung cancer	2.86e-05	0.000197	CcSEcCtD
Clomipramine—Abdominal pain—Docetaxel—lung cancer	2.85e-05	0.000196	CcSEcCtD
Clomipramine—Body temperature increased—Docetaxel—lung cancer	2.85e-05	0.000196	CcSEcCtD
Clomipramine—Leukopenia—Methotrexate—lung cancer	2.85e-05	0.000196	CcSEcCtD
Clomipramine—Chills—Doxorubicin—lung cancer	2.85e-05	0.000196	CcSEcCtD
Clomipramine—Arrhythmia—Doxorubicin—lung cancer	2.83e-05	0.000195	CcSEcCtD
Clomipramine—Dizziness—Paclitaxel—lung cancer	2.82e-05	0.000194	CcSEcCtD
Clomipramine—Nausea—Cisplatin—lung cancer	2.82e-05	0.000194	CcSEcCtD
Clomipramine—Chlorpromazine—ABCB1—lung cancer	2.81e-05	0.0169	CrCbGaD
Clomipramine—Alopecia—Doxorubicin—lung cancer	2.8e-05	0.000193	CcSEcCtD
Clomipramine—Imipramine—ABCB1—lung cancer	2.79e-05	0.0168	CrCbGaD
Clomipramine—Cough—Methotrexate—lung cancer	2.78e-05	0.000191	CcSEcCtD
Clomipramine—Mental disorder—Doxorubicin—lung cancer	2.78e-05	0.000191	CcSEcCtD
Clomipramine—Amitriptyline—ABCB1—lung cancer	2.77e-05	0.0167	CrCbGaD
Clomipramine—Convulsion—Methotrexate—lung cancer	2.76e-05	0.00019	CcSEcCtD
Clomipramine—Vomiting—Etoposide—lung cancer	2.76e-05	0.00019	CcSEcCtD
Clomipramine—Malnutrition—Doxorubicin—lung cancer	2.76e-05	0.00019	CcSEcCtD
Clomipramine—Rash—Etoposide—lung cancer	2.74e-05	0.000188	CcSEcCtD
Clomipramine—Dermatitis—Etoposide—lung cancer	2.74e-05	0.000188	CcSEcCtD
Clomipramine—Headache—Etoposide—lung cancer	2.72e-05	0.000187	CcSEcCtD
Clomipramine—Flatulence—Doxorubicin—lung cancer	2.72e-05	0.000187	CcSEcCtD
Clomipramine—Chest pain—Methotrexate—lung cancer	2.71e-05	0.000187	CcSEcCtD
Clomipramine—Myalgia—Methotrexate—lung cancer	2.71e-05	0.000187	CcSEcCtD
Clomipramine—Arthralgia—Methotrexate—lung cancer	2.71e-05	0.000187	CcSEcCtD
Clomipramine—Tension—Doxorubicin—lung cancer	2.71e-05	0.000186	CcSEcCtD
Clomipramine—Vomiting—Paclitaxel—lung cancer	2.71e-05	0.000186	CcSEcCtD
Clomipramine—Dysgeusia—Doxorubicin—lung cancer	2.7e-05	0.000186	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	2.7e-05	0.000185	CcSEcCtD
Clomipramine—Rash—Paclitaxel—lung cancer	2.69e-05	0.000185	CcSEcCtD
Clomipramine—Dermatitis—Paclitaxel—lung cancer	2.68e-05	0.000185	CcSEcCtD
Clomipramine—Discomfort—Methotrexate—lung cancer	2.68e-05	0.000184	CcSEcCtD
Clomipramine—Nervousness—Doxorubicin—lung cancer	2.68e-05	0.000184	CcSEcCtD
Clomipramine—Back pain—Doxorubicin—lung cancer	2.67e-05	0.000184	CcSEcCtD
Clomipramine—Headache—Paclitaxel—lung cancer	2.67e-05	0.000184	CcSEcCtD
Clomipramine—Hypersensitivity—Docetaxel—lung cancer	2.66e-05	0.000183	CcSEcCtD
Clomipramine—Muscle spasms—Doxorubicin—lung cancer	2.65e-05	0.000183	CcSEcCtD
Clomipramine—Confusional state—Methotrexate—lung cancer	2.62e-05	0.00018	CcSEcCtD
Clomipramine—Anaphylactic shock—Methotrexate—lung cancer	2.6e-05	0.000179	CcSEcCtD
Clomipramine—Vision blurred—Doxorubicin—lung cancer	2.6e-05	0.000179	CcSEcCtD
Clomipramine—Asthenia—Docetaxel—lung cancer	2.59e-05	0.000178	CcSEcCtD
Clomipramine—Nausea—Etoposide—lung cancer	2.58e-05	0.000177	CcSEcCtD
Clomipramine—Ill-defined disorder—Doxorubicin—lung cancer	2.56e-05	0.000176	CcSEcCtD
Clomipramine—Pruritus—Docetaxel—lung cancer	2.55e-05	0.000176	CcSEcCtD
Clomipramine—Nervous system disorder—Methotrexate—lung cancer	2.55e-05	0.000175	CcSEcCtD
Clomipramine—Anaemia—Doxorubicin—lung cancer	2.55e-05	0.000175	CcSEcCtD
Clomipramine—Thrombocytopenia—Methotrexate—lung cancer	2.55e-05	0.000175	CcSEcCtD
Clomipramine—Agitation—Doxorubicin—lung cancer	2.54e-05	0.000174	CcSEcCtD
Clomipramine—Nausea—Paclitaxel—lung cancer	2.53e-05	0.000174	CcSEcCtD
Clomipramine—Skin disorder—Methotrexate—lung cancer	2.53e-05	0.000174	CcSEcCtD
Clomipramine—Hyperhidrosis—Methotrexate—lung cancer	2.52e-05	0.000173	CcSEcCtD
Clomipramine—Malaise—Doxorubicin—lung cancer	2.49e-05	0.000171	CcSEcCtD
Clomipramine—Vertigo—Doxorubicin—lung cancer	2.48e-05	0.000171	CcSEcCtD
Clomipramine—Anorexia—Methotrexate—lung cancer	2.48e-05	0.000171	CcSEcCtD
Clomipramine—Syncope—Doxorubicin—lung cancer	2.48e-05	0.00017	CcSEcCtD
Clomipramine—Leukopenia—Doxorubicin—lung cancer	2.47e-05	0.00017	CcSEcCtD
Clomipramine—Diarrhoea—Docetaxel—lung cancer	2.47e-05	0.00017	CcSEcCtD
Clomipramine—Palpitations—Doxorubicin—lung cancer	2.44e-05	0.000168	CcSEcCtD
Clomipramine—Hypotension—Methotrexate—lung cancer	2.43e-05	0.000167	CcSEcCtD
Clomipramine—Loss of consciousness—Doxorubicin—lung cancer	2.43e-05	0.000167	CcSEcCtD
Clomipramine—Cough—Doxorubicin—lung cancer	2.41e-05	0.000166	CcSEcCtD
Clomipramine—Convulsion—Doxorubicin—lung cancer	2.39e-05	0.000165	CcSEcCtD
Clomipramine—Dizziness—Docetaxel—lung cancer	2.39e-05	0.000164	CcSEcCtD
Clomipramine—Hypertension—Doxorubicin—lung cancer	2.38e-05	0.000164	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Methotrexate—lung cancer	2.37e-05	0.000163	CcSEcCtD
Clomipramine—Insomnia—Methotrexate—lung cancer	2.35e-05	0.000162	CcSEcCtD
Clomipramine—Chest pain—Doxorubicin—lung cancer	2.35e-05	0.000162	CcSEcCtD
Clomipramine—Arthralgia—Doxorubicin—lung cancer	2.35e-05	0.000162	CcSEcCtD
Clomipramine—Myalgia—Doxorubicin—lung cancer	2.35e-05	0.000162	CcSEcCtD
Clomipramine—Anxiety—Doxorubicin—lung cancer	2.34e-05	0.000161	CcSEcCtD
Clomipramine—Paraesthesia—Methotrexate—lung cancer	2.34e-05	0.000161	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	2.33e-05	0.000161	CcSEcCtD
Clomipramine—Discomfort—Doxorubicin—lung cancer	2.32e-05	0.00016	CcSEcCtD
Clomipramine—Dyspnoea—Methotrexate—lung cancer	2.32e-05	0.00016	CcSEcCtD
Clomipramine—Somnolence—Methotrexate—lung cancer	2.31e-05	0.000159	CcSEcCtD
Clomipramine—Dry mouth—Doxorubicin—lung cancer	2.3e-05	0.000158	CcSEcCtD
Clomipramine—Vomiting—Docetaxel—lung cancer	2.3e-05	0.000158	CcSEcCtD
Clomipramine—Dyspepsia—Methotrexate—lung cancer	2.29e-05	0.000158	CcSEcCtD
Clomipramine—Rash—Docetaxel—lung cancer	2.28e-05	0.000157	CcSEcCtD
Clomipramine—Dermatitis—Docetaxel—lung cancer	2.27e-05	0.000156	CcSEcCtD
Clomipramine—Confusional state—Doxorubicin—lung cancer	2.27e-05	0.000156	CcSEcCtD
Clomipramine—Decreased appetite—Methotrexate—lung cancer	2.26e-05	0.000156	CcSEcCtD
Clomipramine—Headache—Docetaxel—lung cancer	2.26e-05	0.000156	CcSEcCtD
Clomipramine—Anaphylactic shock—Doxorubicin—lung cancer	2.25e-05	0.000155	CcSEcCtD
Clomipramine—Oedema—Doxorubicin—lung cancer	2.25e-05	0.000155	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Methotrexate—lung cancer	2.25e-05	0.000154	CcSEcCtD
Clomipramine—Fatigue—Methotrexate—lung cancer	2.24e-05	0.000154	CcSEcCtD
Clomipramine—Pain—Methotrexate—lung cancer	2.22e-05	0.000153	CcSEcCtD
Clomipramine—Shock—Doxorubicin—lung cancer	2.22e-05	0.000152	CcSEcCtD
Clomipramine—Nervous system disorder—Doxorubicin—lung cancer	2.21e-05	0.000152	CcSEcCtD
Clomipramine—Thrombocytopenia—Doxorubicin—lung cancer	2.21e-05	0.000152	CcSEcCtD
Clomipramine—Tachycardia—Doxorubicin—lung cancer	2.2e-05	0.000151	CcSEcCtD
Clomipramine—Skin disorder—Doxorubicin—lung cancer	2.19e-05	0.000151	CcSEcCtD
Clomipramine—Hyperhidrosis—Doxorubicin—lung cancer	2.18e-05	0.00015	CcSEcCtD
Clomipramine—Anorexia—Doxorubicin—lung cancer	2.15e-05	0.000148	CcSEcCtD
Clomipramine—Nausea—Docetaxel—lung cancer	2.14e-05	0.000147	CcSEcCtD
Clomipramine—Feeling abnormal—Methotrexate—lung cancer	2.14e-05	0.000147	CcSEcCtD
Clomipramine—Gastrointestinal pain—Methotrexate—lung cancer	2.13e-05	0.000146	CcSEcCtD
Clomipramine—Hypotension—Doxorubicin—lung cancer	2.11e-05	0.000145	CcSEcCtD
Clomipramine—Urticaria—Methotrexate—lung cancer	2.07e-05	0.000142	CcSEcCtD
Clomipramine—Abdominal pain—Methotrexate—lung cancer	2.06e-05	0.000141	CcSEcCtD
Clomipramine—Body temperature increased—Methotrexate—lung cancer	2.06e-05	0.000141	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Doxorubicin—lung cancer	2.05e-05	0.000141	CcSEcCtD
Clomipramine—Insomnia—Doxorubicin—lung cancer	2.04e-05	0.00014	CcSEcCtD
Clomipramine—Paraesthesia—Doxorubicin—lung cancer	2.02e-05	0.000139	CcSEcCtD
Clomipramine—Dyspnoea—Doxorubicin—lung cancer	2.01e-05	0.000138	CcSEcCtD
Clomipramine—Somnolence—Doxorubicin—lung cancer	2e-05	0.000138	CcSEcCtD
Clomipramine—Dyspepsia—Doxorubicin—lung cancer	1.98e-05	0.000136	CcSEcCtD
Clomipramine—Decreased appetite—Doxorubicin—lung cancer	1.96e-05	0.000135	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Doxorubicin—lung cancer	1.95e-05	0.000134	CcSEcCtD
Clomipramine—Fatigue—Doxorubicin—lung cancer	1.94e-05	0.000134	CcSEcCtD
Clomipramine—Constipation—Doxorubicin—lung cancer	1.93e-05	0.000133	CcSEcCtD
Clomipramine—Pain—Doxorubicin—lung cancer	1.93e-05	0.000133	CcSEcCtD
Clomipramine—Hypersensitivity—Methotrexate—lung cancer	1.92e-05	0.000132	CcSEcCtD
Clomipramine—Asthenia—Methotrexate—lung cancer	1.87e-05	0.000128	CcSEcCtD
Clomipramine—Feeling abnormal—Doxorubicin—lung cancer	1.86e-05	0.000128	CcSEcCtD
Clomipramine—Gastrointestinal pain—Doxorubicin—lung cancer	1.84e-05	0.000127	CcSEcCtD
Clomipramine—Pruritus—Methotrexate—lung cancer	1.84e-05	0.000127	CcSEcCtD
Clomipramine—Urticaria—Doxorubicin—lung cancer	1.79e-05	0.000123	CcSEcCtD
Clomipramine—Abdominal pain—Doxorubicin—lung cancer	1.78e-05	0.000122	CcSEcCtD
Clomipramine—Body temperature increased—Doxorubicin—lung cancer	1.78e-05	0.000122	CcSEcCtD
Clomipramine—Diarrhoea—Methotrexate—lung cancer	1.78e-05	0.000122	CcSEcCtD
Clomipramine—Dizziness—Methotrexate—lung cancer	1.72e-05	0.000118	CcSEcCtD
Clomipramine—Hypersensitivity—Doxorubicin—lung cancer	1.66e-05	0.000114	CcSEcCtD
Clomipramine—Vomiting—Methotrexate—lung cancer	1.65e-05	0.000114	CcSEcCtD
Clomipramine—Rash—Methotrexate—lung cancer	1.64e-05	0.000113	CcSEcCtD
Clomipramine—Dermatitis—Methotrexate—lung cancer	1.64e-05	0.000113	CcSEcCtD
Clomipramine—Headache—Methotrexate—lung cancer	1.63e-05	0.000112	CcSEcCtD
Clomipramine—Asthenia—Doxorubicin—lung cancer	1.62e-05	0.000111	CcSEcCtD
Clomipramine—Pruritus—Doxorubicin—lung cancer	1.59e-05	0.00011	CcSEcCtD
Clomipramine—Nausea—Methotrexate—lung cancer	1.55e-05	0.000106	CcSEcCtD
Clomipramine—Diarrhoea—Doxorubicin—lung cancer	1.54e-05	0.000106	CcSEcCtD
Clomipramine—Dizziness—Doxorubicin—lung cancer	1.49e-05	0.000102	CcSEcCtD
Clomipramine—Vomiting—Doxorubicin—lung cancer	1.43e-05	9.85e-05	CcSEcCtD
Clomipramine—Rash—Doxorubicin—lung cancer	1.42e-05	9.77e-05	CcSEcCtD
Clomipramine—Dermatitis—Doxorubicin—lung cancer	1.42e-05	9.76e-05	CcSEcCtD
Clomipramine—Headache—Doxorubicin—lung cancer	1.41e-05	9.71e-05	CcSEcCtD
Clomipramine—Nausea—Doxorubicin—lung cancer	1.34e-05	9.2e-05	CcSEcCtD
Clomipramine—HTR2A—Signaling Pathways—CREBBP—lung cancer	2.78e-06	3.69e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—STAT3—lung cancer	2.77e-06	3.68e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—NRAS—lung cancer	2.76e-06	3.67e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—AKT1—lung cancer	2.76e-06	3.66e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—TP53—lung cancer	2.76e-06	3.66e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ENO1—lung cancer	2.75e-06	3.65e-05	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—HRAS—lung cancer	2.74e-06	3.64e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—EGFR—lung cancer	2.73e-06	3.62e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—PIK3CA—lung cancer	2.73e-06	3.62e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—APC—lung cancer	2.72e-06	3.62e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—KIT—lung cancer	2.72e-06	3.62e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PIK3CG—lung cancer	2.72e-06	3.62e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—NRAS—lung cancer	2.72e-06	3.62e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—MDM2—lung cancer	2.71e-06	3.6e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—CYP1A1—lung cancer	2.71e-06	3.6e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—RAF1—lung cancer	2.71e-06	3.59e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—EP300—lung cancer	2.7e-06	3.58e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.7e-06	3.58e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—EGF—lung cancer	2.69e-06	3.57e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—ERCC2—lung cancer	2.69e-06	3.57e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—ERBB2—lung cancer	2.68e-06	3.55e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.67e-06	3.55e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MAP2K1—lung cancer	2.65e-06	3.52e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—MAPK3—lung cancer	2.65e-06	3.52e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—PIK3CB—lung cancer	2.64e-06	3.51e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—MTOR—lung cancer	2.64e-06	3.51e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—HRAS—lung cancer	2.64e-06	3.5e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—GSTP1—lung cancer	2.63e-06	3.5e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—PIK3CD—lung cancer	2.63e-06	3.49e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—SRC—lung cancer	2.62e-06	3.48e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—MAPK3—lung cancer	2.61e-06	3.46e-05	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—PIK3CA—lung cancer	2.61e-06	3.46e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—POMC—lung cancer	2.59e-06	3.44e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—KRAS—lung cancer	2.58e-06	3.42e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—MYC—lung cancer	2.58e-06	3.42e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PIK3CG—lung cancer	2.57e-06	3.41e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CAT—lung cancer	2.56e-06	3.4e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—BRAF—lung cancer	2.56e-06	3.4e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—VEGFA—lung cancer	2.56e-06	3.39e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.55e-06	3.38e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CXCL8—lung cancer	2.54e-06	3.37e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—STAT3—lung cancer	2.53e-06	3.36e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IL6R—lung cancer	2.53e-06	3.36e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—APOA1—lung cancer	2.53e-06	3.36e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CREBBP—lung cancer	2.52e-06	3.35e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—IL6—lung cancer	2.52e-06	3.35e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—NRAS—lung cancer	2.52e-06	3.35e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—HRAS—lung cancer	2.52e-06	3.35e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—EGFR—lung cancer	2.52e-06	3.35e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—PIK3CB—lung cancer	2.5e-06	3.31e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—ABCB1—lung cancer	2.49e-06	3.31e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—EGFR—lung cancer	2.48e-06	3.29e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—PTGS2—lung cancer	2.47e-06	3.28e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—APOA1—lung cancer	2.47e-06	3.28e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CYP2E1—lung cancer	2.47e-06	3.27e-05	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—AKT1—lung cancer	2.45e-06	3.26e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—TYMS—lung cancer	2.45e-06	3.25e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—POMC—lung cancer	2.45e-06	3.25e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—NQO1—lung cancer	2.44e-06	3.24e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CASP3—lung cancer	2.43e-06	3.23e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—IL2—lung cancer	2.43e-06	3.22e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—GSTM1—lung cancer	2.42e-06	3.21e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.42e-06	3.21e-05	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—AKT1—lung cancer	2.42e-06	3.21e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—MAPK3—lung cancer	2.42e-06	3.21e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—IL6—lung cancer	2.41e-06	3.2e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MAP2K1—lung cancer	2.41e-06	3.2e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PIK3CD—lung cancer	2.39e-06	3.18e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—CREBBP—lung cancer	2.38e-06	3.16e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—KRAS—lung cancer	2.38e-06	3.16e-05	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—PIK3CA—lung cancer	2.37e-06	3.15e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—PIK3CA—lung cancer	2.37e-06	3.14e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CCND1—lung cancer	2.36e-06	3.14e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—JUN—lung cancer	2.36e-06	3.13e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MDM2—lung cancer	2.36e-06	3.13e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—MYC—lung cancer	2.35e-06	3.12e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—RAF1—lung cancer	2.35e-06	3.12e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—KRAS—lung cancer	2.34e-06	3.11e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—AKT1—lung cancer	2.33e-06	3.09e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—APOA1—lung cancer	2.32e-06	3.09e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—ERBB2—lung cancer	2.32e-06	3.09e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PIK3CG—lung cancer	2.31e-06	3.06e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—EGFR—lung cancer	2.3e-06	3.05e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—MMP9—lung cancer	2.3e-06	3.05e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CYP1A1—lung cancer	2.3e-06	3.05e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MTOR—lung cancer	2.29e-06	3.05e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—PIK3CB—lung cancer	2.29e-06	3.05e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CDKN1A—lung cancer	2.29e-06	3.04e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—PTEN—lung cancer	2.28e-06	3.03e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—ERCC2—lung cancer	2.28e-06	3.02e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PIK3CD—lung cancer	2.26e-06	3e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PIK3CG—lung cancer	2.25e-06	2.99e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—AKT1—lung cancer	2.23e-06	2.96e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CXCL8—lung cancer	2.2e-06	2.93e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—STK11—lung cancer	2.2e-06	2.92e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—POMC—lung cancer	2.2e-06	2.92e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—HRAS—lung cancer	2.19e-06	2.91e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—PIK3CA—lung cancer	2.19e-06	2.9e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—EP300—lung cancer	2.18e-06	2.89e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—KRAS—lung cancer	2.17e-06	2.88e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—PTEN—lung cancer	2.16e-06	2.86e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—PIK3CA—lung cancer	2.15e-06	2.86e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MDM2—lung cancer	2.14e-06	2.85e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—POMC—lung cancer	2.14e-06	2.85e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—CREBBP—lung cancer	2.14e-06	2.84e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—RAF1—lung cancer	2.14e-06	2.84e-05	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—AKT1—lung cancer	2.13e-06	2.83e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PIK3CG—lung cancer	2.12e-06	2.82e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—SRC—lung cancer	2.12e-06	2.81e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—TP53—lung cancer	2.12e-06	2.81e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—ERBB2—lung cancer	2.11e-06	2.81e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CASP3—lung cancer	2.11e-06	2.8e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IL2—lung cancer	2.11e-06	2.8e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—IL6—lung cancer	2.1e-06	2.78e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—CREBBP—lung cancer	2.09e-06	2.77e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MTOR—lung cancer	2.09e-06	2.77e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PIK3CB—lung cancer	2.09e-06	2.77e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—VEGFA—lung cancer	2.06e-06	2.74e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—EP300—lung cancer	2.06e-06	2.73e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CCND1—lung cancer	2.05e-06	2.73e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—JUN—lung cancer	2.05e-06	2.72e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—STAT3—lung cancer	2.04e-06	2.71e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—NRAS—lung cancer	2.04e-06	2.7e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GSTP1—lung cancer	2.03e-06	2.7e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PIK3CD—lung cancer	2.03e-06	2.69e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—HRAS—lung cancer	2.02e-06	2.69e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—POMC—lung cancer	2.02e-06	2.68e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CXCL8—lung cancer	2.01e-06	2.66e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—ALB—lung cancer	2e-06	2.66e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—PIK3CA—lung cancer	2e-06	2.65e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MMP9—lung cancer	1.99e-06	2.65e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—HRAS—lung cancer	1.99e-06	2.65e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CDKN1A—lung cancer	1.99e-06	2.64e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—PTEN—lung cancer	1.98e-06	2.63e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PIK3CD—lung cancer	1.98e-06	2.63e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CAT—lung cancer	1.98e-06	2.63e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PIK3CB—lung cancer	1.97e-06	2.62e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—APOA1—lung cancer	1.97e-06	2.61e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—CREBBP—lung cancer	1.97e-06	2.61e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—ALB—lung cancer	1.95e-06	2.6e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PTGS2—lung cancer	1.95e-06	2.59e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—MAPK3—lung cancer	1.95e-06	2.59e-05	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—AKT1—lung cancer	1.94e-06	2.57e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—IL6—lung cancer	1.94e-06	2.57e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—AKT1—lung cancer	1.93e-06	2.57e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—TP53—lung cancer	1.93e-06	2.56e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ABCB1—lung cancer	1.92e-06	2.56e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CASP3—lung cancer	1.92e-06	2.55e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IL2—lung cancer	1.92e-06	2.54e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—IL6—lung cancer	1.91e-06	2.53e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—MYC—lung cancer	1.9e-06	2.52e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—TYMS—lung cancer	1.89e-06	2.51e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—EP300—lung cancer	1.89e-06	2.51e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.89e-06	2.5e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GSTM1—lung cancer	1.87e-06	2.48e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CCND1—lung cancer	1.87e-06	2.48e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PIK3CD—lung cancer	1.87e-06	2.48e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—JUN—lung cancer	1.86e-06	2.48e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—EGFR—lung cancer	1.86e-06	2.46e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—HRAS—lung cancer	1.85e-06	2.45e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—ALB—lung cancer	1.84e-06	2.45e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—SRC—lung cancer	1.84e-06	2.44e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MMP9—lung cancer	1.81e-06	2.41e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CDKN1A—lung cancer	1.81e-06	2.4e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PTEN—lung cancer	1.8e-06	2.39e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PIK3CG—lung cancer	1.8e-06	2.39e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—VEGFA—lung cancer	1.79e-06	2.38e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—AKT1—lung cancer	1.79e-06	2.37e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—STAT3—lung cancer	1.77e-06	2.35e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CYP1A1—lung cancer	1.77e-06	2.35e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—NRAS—lung cancer	1.77e-06	2.35e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PIK3CB—lung cancer	1.77e-06	2.35e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—IL6—lung cancer	1.77e-06	2.35e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—AKT1—lung cancer	1.76e-06	2.34e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ERCC2—lung cancer	1.76e-06	2.33e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—KRAS—lung cancer	1.75e-06	2.33e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PTGS2—lung cancer	1.75e-06	2.33e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PIK3CB—lung cancer	1.73e-06	2.29e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—EP300—lung cancer	1.72e-06	2.28e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—POMC—lung cancer	1.71e-06	2.27e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PTGS2—lung cancer	1.71e-06	2.27e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PTEN—lung cancer	1.7e-06	2.26e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MAPK3—lung cancer	1.69e-06	2.25e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—SRC—lung cancer	1.67e-06	2.22e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CREBBP—lung cancer	1.67e-06	2.21e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MYC—lung cancer	1.65e-06	2.19e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—AKT1—lung cancer	1.63e-06	2.16e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—VEGFA—lung cancer	1.63e-06	2.16e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PIK3CB—lung cancer	1.63e-06	2.16e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—EP300—lung cancer	1.62e-06	2.16e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—STAT3—lung cancer	1.61e-06	2.14e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PTGS2—lung cancer	1.61e-06	2.14e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—EGFR—lung cancer	1.61e-06	2.14e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—PIK3CA—lung cancer	1.61e-06	2.14e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—NRAS—lung cancer	1.61e-06	2.14e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PIK3CD—lung cancer	1.58e-06	2.1e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—ALB—lung cancer	1.56e-06	2.07e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—TP53—lung cancer	1.56e-06	2.07e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MAPK3—lung cancer	1.54e-06	2.05e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PTEN—lung cancer	1.53e-06	2.03e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—KRAS—lung cancer	1.52e-06	2.02e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—PIK3CA—lung cancer	1.52e-06	2.02e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—APOA1—lung cancer	1.52e-06	2.02e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MYC—lung cancer	1.5e-06	1.99e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PTEN—lung cancer	1.49e-06	1.98e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—HRAS—lung cancer	1.49e-06	1.98e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—EGFR—lung cancer	1.47e-06	1.95e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—EP300—lung cancer	1.46e-06	1.93e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—IL6—lung cancer	1.43e-06	1.89e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—EP300—lung cancer	1.42e-06	1.89e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PTEN—lung cancer	1.41e-06	1.87e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—PIK3CA—lung cancer	1.4e-06	1.86e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PIK3CG—lung cancer	1.39e-06	1.84e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—KRAS—lung cancer	1.38e-06	1.84e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PIK3CB—lung cancer	1.38e-06	1.83e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PTGS2—lung cancer	1.36e-06	1.81e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—TP53—lung cancer	1.35e-06	1.8e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—EP300—lung cancer	1.34e-06	1.78e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—POMC—lung cancer	1.32e-06	1.75e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—AKT1—lung cancer	1.32e-06	1.75e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—HRAS—lung cancer	1.29e-06	1.72e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CREBBP—lung cancer	1.29e-06	1.71e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PIK3CA—lung cancer	1.27e-06	1.69e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—AKT1—lung cancer	1.24e-06	1.65e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IL6—lung cancer	1.24e-06	1.64e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—TP53—lung cancer	1.23e-06	1.63e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PIK3CD—lung cancer	1.22e-06	1.62e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ALB—lung cancer	1.2e-06	1.6e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PIK3CA—lung cancer	1.2e-06	1.59e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PTEN—lung cancer	1.19e-06	1.58e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—HRAS—lung cancer	1.18e-06	1.56e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—AKT1—lung cancer	1.14e-06	1.52e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—EP300—lung cancer	1.14e-06	1.51e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IL6—lung cancer	1.13e-06	1.5e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PIK3CA—lung cancer	1.08e-06	1.43e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PIK3CB—lung cancer	1.06e-06	1.41e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PTGS2—lung cancer	1.05e-06	1.4e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PIK3CA—lung cancer	1.05e-06	1.4e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—AKT1—lung cancer	1.04e-06	1.38e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PIK3CA—lung cancer	9.91e-07	1.32e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—AKT1—lung cancer	9.81e-07	1.3e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PTEN—lung cancer	9.19e-07	1.22e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—AKT1—lung cancer	8.8e-07	1.17e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—EP300—lung cancer	8.76e-07	1.16e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—AKT1—lung cancer	8.59e-07	1.14e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PIK3CA—lung cancer	8.4e-07	1.12e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—AKT1—lung cancer	8.1e-07	1.08e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—AKT1—lung cancer	6.86e-07	9.11e-06	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PIK3CA—lung cancer	6.48e-07	8.61e-06	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—AKT1—lung cancer	5.29e-07	7.03e-06	CbGpPWpGaD
